Trials / Withdrawn
WithdrawnNCT03814148
Efficacy and Safety of Leningrado 5 Association in the Treatment of Hypertension
Randomized, Double-blind, Double-dummy, National, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Leningrado 5 Association in the Treatment of Hypertension
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Leningrado 5 association on the treatment of hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LENINGRADO 5 association | 1 coated sustained-release tablet, oral, once a day. |
| DRUG | Natrilix® SR | 1 coated sustained-release tablet, oral, once a day. |
| OTHER | Natrilix SR Placebo | 1 coated sustained-release tablet, oral, once a day. |
| OTHER | Leningrado 5 association Placebo | 1 coated sustained-release tablet, oral, once a day. |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2020-06-01
- Completion
- 2020-09-01
- First posted
- 2019-01-23
- Last updated
- 2021-02-24
Source: ClinicalTrials.gov record NCT03814148. Inclusion in this directory is not an endorsement.